SAPA Business Directory

 

Excel PharmaStudies, Inc. (Corporate and Silver Sponsor) 

Excel PharmaStudies, Inc. is a full-service provider of clinical research, registration, biometrics, and training and consultation services. Excel is the leading CRO in China. With 17 offices worldwide, nearly 300 staff members, and experience working with over 120 of the world's leading global pharmaceutical and biotech companies. Excel PharmaStudies, Inc. has the resources, connections, and expertise needed to help you with all of your drug development needs in Asia.

 

 

WuXi AppTec. Inc. (Special and Silver Sponsor) 

WuXi AppTec is a leading global pharmaceutical, biopharmaceutical and medical device outsourcing company with operations in China and the United States. As a research-driven and customer-focused company, WuXi AppTec provides a broad and integrated portfolio of laboratory and manufacturing services across the discovery-to-commercialization spectrum. Our services are designed to assist our customers worldwide in shortening the time and lowering the cost of drug and medical device R&D by providing cost-effective and efficient outsourcing solutions.

 

Roche (Silver Sponsor)

At Roche, about 80,000 people across 150 countries are pushing back the frontiers of healthcare. Working together, we've become one of the world's leading research-focused healthcare groups. Our success is built on innovation, curiosity and diversity, and on seeing each other's differences as an advantage. Roche R&D Center (China) Ltd., the first drug discovery R&D center in China owned by a global healthcare company, was established in 2004. RRDCC research team has also grown 20 medicinal chemists by end of 2004, to a team of over 80 research scientists by 2008, from different disciplines like biology, screening, medicinal chemistry, DMPK, molecular design and biostructure, as well as research technology, etc.
Though initially focused on medicinal chemistry research in lead generation and optimization, RRDCC is operating under a new drug discovery model in China. Under this operation, DBA will approve the targets or assets that are brought into RRDCC portfolio. Then, RRDCC will have the decision rights across the value chain. Once proof of concept is realized in the clinic, SPC will decide to either bring or not bring that asset into the global portfolio. In this model, RRDCC will maintain its core internal competency in house while flexibly rely on expertise of external partners. RRDCC will focus on diseases that are more prevalent in the Asia-Pacific Rim and bringing important drugs to the Chinese market as well as global market to meet the unmet medical needs.

 

PharmaLegacy (Silver Sponsor)

PharmaLegacy Laboratories is a preclinical Contract Research Organization (CRO)  providing specialty pharmacology services in Bone Metabolism, Immune Diseases, Inflammation, Orthopaedics and Tissue Engineering, and Tumor. The core competency of PharmaLegacy stems from our pioneering work and expertise in developing and running specialized animal models to test drug candidates and medical devices for their pharmacological effects and biocompatible repairs. We also conduct adjacency studies in PK/PD, molecular pharmacology and preliminary toxicology. Overall we provide one-stop shopping of preclinical pharmacology services for early proof of concept of therapeutics and fulfillment of regulatory requirement.

 

We have fully established animal pharmacology models of rodents, dogs, mini-pigs, sheep/goats and non-human primates which are used to serve our current clients of large multinational pharmaceutical and medical device companies, as well as small- to medium-sized biotech companies.

 

Delivering premium quality and securing the highest IP protection are the lifeblood of our services.

          Our whole operation is based on international GLP and QA system.

          Our research data is electronically managed by BioBook (IDBS, UK).

          We have a 45,000 ft2 facility with 17,000 ft2 of SPF and conventional vivarium to house 10,000 rodents and large animals.

          We are able to run 200 animal studies concurrently following strictly the guidelines of AAALAC and ILAC.

          Our web-based live video streaming allows remote monitoring of operations details worldwide.

          We partner with two premium non-human primate centers having 4,000 monkeys’ (Cynomolgus and Rhesus) capacity.

          US office for support and shipping logistics

          24/7 access to PharmaLegacy representatives.

 

Ratner Prestia (Silver Sponsor)

 An intellectual property boutique, Panitch Schwarze Belisario & Nadel LLP was officially established on January 1, 2008.  Although the name is new, a common thread connects our team of intellectual property professionals, most of whom have practiced together for decades, including 18 years with the former Panitch Schwarze Jacobs & Nadel firm, and more recently, 8 years with Akin Gump Strauss Hauer & Feld LLP. Panitch Schwarze Belisario & Nadel adopts a team approach, encouraging the collaboration of our patent, trademark, and copyright professionals so as to maximize client protection. We have long-standing relationships with a network of foreign associates in countries around the world, allowing us to provide clients with global protection of their intellectual property assets.

Our attorneys attend international conferences and meet with foreign associates regularly to ensure that our clients are well-represented with a comprehensive IP protection and enforcement strategy both domestically and abroad. Many of our attorneys have also written and lectured extensively, with articles featured in journals such as The National Law Journal, Science and Nature, The Pennsylvania Lawyer, and BusinessWeek. Our four named partners have been repeatedly featured in Chambers USA, and are all included on this year’s Pennsylvania Super Lawyers list. The firm’s clientele spans across industries, running the gamut from the pharmaceutical industry to the gaming and toy industry. Whether assisting an individual inventor in securing a trademark or representing a Fortune 500 company in high stakes litigation, Panitch Schwarze Belisario & Nadel address each client need with the responsiveness and  personalized attention characteristic of a sophisticated boutique firm.

 

 

Frontage Laboratories (Annual Conference & Bronze Sponsor)

 Frontage Laboratories, Inc. is a collaborative R&D company dedicated to advancing the development efforts of pharmaceutical companies around the world with our expertise in Preclinical, Clinical Pharmacology, CMC services including formulation development , pharmaceutical analysis and clinical trial supply (sterile liquids and solids), Clinical Phase I, and Bioanalytical services. We specialize in assisting our partners to resolve complex product development challenges through our integrated services and divisions in the United States and China.

Frontage Laboratories, Inc. has a passion for detail and on-time service delivery. We have an experienced management team and scientific staff, most of whom have gained their training and knowledge from working at such notable companies as Wyeth, Merck, GSK, Johnson & Johnson, AstraZeneca, Pfizer, Novartis, BMS and Aventis. We are fully compliant with all cGMP/GLP/GCP regulations and our current clientele is diverse from large pharma and biotech companies to drug discovery and generic pharmaceutical companies.

 

 

Pharmaron (Annual Conference & Bronze Sponsor)

Pharmaron is premier R&D service providers for the pharmaceutical industry, helping clients advance their projects in a timely and cost effective manner. With a world-class team of over 500 scientists and highly experienced and accomplished management in the US and China, Pharmaron provides partners with optimal outsourcing solutions in the drug discovery area, including synthetic and high throughput library chemistry, medicinal chemistry, biology, DMPK, in vivo pharmacology, process development and large scale manufacturing. In addition to strong stand-alone services in each area, Pharmaron also offers integrated drug discovery and development services.

 

Chemistry Services

In vitro ADMET and in vivo PK in rodent

·         Medicinal Chemistry

·                   Physical chemical properties assess.

·         Focused Libraries

·                   Metabolic stability

·         Customer Synthesis

·                   Protein binding

·         Process development

·                   Caco-2 / PAMPA / MDCK permeability

·                     Scale-up Synthesis

·                   CYP phenotyping

·                     Process development/manufacture

·                   In vivo PK in rat and mouse

Biology Services

In vivo Pharmacology Services

·                     Assay development

·                     Compound profiling

·                     In vitro pharmacology and toxicity

·                   Oncology animal models

·                   CNS – pain model

 

 

ChemPartner (Bronze Sponsor)

Founded in 2003, Shanghai ChemPartner Co., Ltd.("ChemPartner") is a R&D contract research company to provide customized services to international pharmaceutical, biotech, agrochemical, and chemical companies. ChemPartner currently has a team of more than 250 scientists, including more than 40 PhDs, who either had extensive oversea R&D experiences in pharmaceutical / biotech companies, universities, or were trained at top chemistry research institutes in China before joining ChemPartner. As a company dedicated to contract research service, ChemPartner offers compelling value to the global pharmaceutical, biotech, chemical, and related companies.

 

ANP Technologies, Inc. (Bronze Sponsor)

Spun out from the U.S. Army Research Laboratory and founded in 2002, ANP Technologies, Inc. is an emerging nanobiotechnology company that offers NIDS® multiplexed Rapid Assays with wireless handheld and automatic readers for biodefense and medical diagnostics, NIDS® HyperBind ELISA plates for biologic drug development (i.e., preclinical and clinical studies), well as nanoencapsulation-based Protein Drug Delivery-related products.

 

 

 

GenScript. (Bronze Sponsor)

 

 

GenScript is a contract research organization (CRO) specialized in drug discovery services. Its service portfolio includes bio-reagent services, assay development & screening, lead optimization, and antibody drug development. Founded in 2002 by seasoned pharmaceutical scientists, GenScript has become the largest Biology CRO in China, with headquarters in US, and subsidiaries in France, Japan and China.

 

Wyeth (Bronze Sponsor)

Headquartered in Madison , New Jersey , is one of the largest research-based pharmaceutical and health care products companies in the world. Wyeth is dedicated to solving the world's most critical health problems through research and development, spending approximately $3.3 billion in overall R&D in 2007. With annual sales of nearly $22.4 billion in 2007 and products sold in more than 145 countries, Wyeth is truly a global health care leader.  The divisions of Wyeth are: Wyeth Pharmaceuticals, Wyeth Consumer Healthcare and Fort Dodge Animal Health. 

Wyeth Pharmaceuticals has a long history of pioneering developments in pharmaceuticals and biotechnology, with leading products in the areas of women's health care, neuroscience, musculoskeletal disorders, vaccines and infectious disease, hemophilia, and oncology. Wyeth also is a leader in the development of nutritional products.  Headquartered in Collegeville , Pennsylvania , Wyeth Pharmaceuticals has global operations consisting of 37 manufacturing facilities in 17 countries and markets products in over 60 nations.

 

 

Panitch Schwarze Belisario&Nadel LLP (Bronze Sponsor)

 An intellectual property boutique, Panitch Schwarze Belisario & Nadel LLP was officially established on January 1, 2008.  Although the name is new, a common thread connects our team of intellectual property professionals, most of whom have practiced together for decades, including 18 years with the former Panitch Schwarze Jacobs & Nadel firm, and more recently, 8 years with Akin Gump Strauss Hauer & Feld LLP. OUR APPROACH: Panitch Schwarze Belisario & Nadel adopts a team approach, encouraging the collaboration of our patent, trademark, and copyright professionals so as to maximize client protection. We have long-standing relationships with a network of foreign associates in countries around the world, allowing us to provide clients with global protection of their intellectual property assets. Our attorneys attend international conferences and meet with foreign associates regularly to ensure that our clients are well-represented with a comprehensive IP protection and enforcement strategy both domestically and abroad.

 

 

Fountain Medical (Bronze Sponsor)

 Fountain Medical Development Corp. is a contract research organization (CRO) offering a full range of ICH GCP compliant clinical research services for multinational clients conducting clinical research in China. The management team of Fountain has decades of combined experience working with the world's leading CRO's and drug developers. In the Chinese CRO market, we fill the void of a service provider that balances high quality with moderate cost. Our extensive global experience in multiple therapeutic areas is unmatched by other local CRO's, and our lower operational cost allows us to pass significant savings on to our clients.

 

 

Jiang Su Heng Rui Medicine Co, LTD (Bronze Sponsor)

Jiangsu Hengrui Medicine Co.,Ltd., www.hrs.com.cnfound in 1970,is a large pharmaceutical with scientific and technological innovation as development force. It has been listed on Shanghai Stock Exchange since 2000 under the symbol 600276. Over the years, based on the principle of “Honesty and trustworthiness, quality first” and with realistic, innovative enterprise spirit, Hengrui has created brand advantage in antineoplastics, surgical drugs, cardiovascular drugs and anti-infective. The sale of its antineoplastics rank the first domestically for several years in China .

Hengrui Medicine was specified national narcotics manufacturer, national key high and new technological enterprise, industrialization base of national ’863 program’(Chinese National Programs for High Technology Research and Development ), and ‘enterprise of abiding by contracts and keeping promises’ in Jiangsu Province. Hengrui will always maintain the idea of ‘science & technology centered, create a healthy life”, aim to establish ‘Chinese patent pharmaceutical enterprise’, and make new leap of development.

 

 

GlaxoSmithKline (Bronze Sponsor)

 Headquartered in the UK and with operations based in the US, we are one of the industry leaders, with an estimated seven per cent of the world's pharmaceutical market.

But being a leader brings responsibility. This means that we care about the impact that we have on the people and places touched by our mission to improve health around the world.

It also means that we must help developing countries where debilitating disease affects millions of people and access to life-changing medicines and vaccines is a problem. To meet this challenge, we are committed to providing discounted medicines where they are needed the most.

As a company with a firm foundation in science, we have a flair for research and a track record of turning that research into powerful, marketable drugs. Every hour we spend more than £300,000 (US$562,000) to find new medicines. We produce medicines that treat six major disease areas – asthma, virus control, infections, mental health, diabetes and digestive conditions. In addition, we are a leader in the important area of vaccines and are developing new treatments for cancer.

We also market other products, many of which are among the market leaders:

 

 

COVANCE (Annual Conference Sponsor)

Covance, with headquarters in Princeton, New Jersey, is one of the world’s largest and most comprehensive drug development services companies, with annual revenues greater than $1.5 billion and more than 8,900 employees in over 20 countries. Covance has the people, processes, client service, and global resource capabilities to respond to biotechnology and pharmaceutical clients’ toughest drug development challenges. With the most comprehensive portfolio of preclinical, clinical development, and commercialization services, Covance provides industry-leading services, the world’s largest central laboratory network, and a global team of clinical trial and commercialization experts. 

 

 

Molecular Targeting Technologies Inc. (Annual Conference Sponsor)

 

A privately held Biotechnology Company located in West Chester, PA, focusing on early-stage innovative technology development and working closely with Universities and Government Agencies. Current areas of development include:

* Medical imaging agents for diagnosis of cardiovascular disease and cancer

* 99mTc-glucarate for cardiac imaging

* Radiohybridization PET probe [64Cu-DO3A-CCND1 PNA-D(CSKC)] for breast cancer imaging

* Nanovesicles (SapC-DOPS) for tumor imaging and therapy

* Recombinant oral rabies vaccine for wildlife

* Anthrax and Botulinum toxin vaccines employing fusion protein technology

MTTI has also licensed worldwide rights to manufacture, sell and/or distribute innovative proprietary fluorescence based technologies and novel bead based technologies from PTI Research Inc. (PTIR).These products include NeuroVue® , CellVue® and Immobilized Steroid Bead product lines for in vitro and in vivo research applications.

 

 

Pan Am Realty (Annual Conference Sponsor)

Pan Am Realty was founded in November of 1982 to serve the needs of potential homeowners and till today that is still our motto, to fulfill the needs of all our clients.

With more than 20years of experience in the industry, we have a wealth of knowledge that not only allows us to understand the market better than most companies.

Our veteran staffs have knowledge and experience to leverage on, so that you know your property is in safe hands. We make sure you will get the best deal available by using our extensive resource of people, information and technology.

 

 

Investment & Trade Office (Annual Conference Sponsor)